These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25529478)

  • 1. Circulating microRNA as a diagnostic marker in populations with type 2 diabetes mellitus and diabetic complications.
    Chien HY; Lee TP; Chen CY; Chiu YH; Lin YC; Lee LS; Li WC
    J Chin Med Assoc; 2015 Apr; 78(4):204-11. PubMed ID: 25529478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating endothelium-enriched microRNA-126 as a potential biomarker for coronary artery disease in type 2 diabetes mellitus patients.
    Al-Kafaji G; Al-Mahroos G; Abdulla Al-Muhtaresh H; Sabry MA; Abdul Razzak R; Salem AH
    Biomarkers; 2017; 22(3-4):268-278. PubMed ID: 27321479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of MicroRNAs in Type 2 Diabetes and Associated Vascular Complications.
    Banerjee J; Nema V; Dhas Y; Mishra N
    Biochimie; 2017 Aug; 139():9-19. PubMed ID: 28487136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of MicroRNA 126 in screening, diagnosis, and prognosis of diabetic patients in Egypt.
    Rezk NA; Sabbah NA; Saad MS
    IUBMB Life; 2016 Jun; 68(6):452-8. PubMed ID: 27118517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA Signatures as Future Biomarkers for Diagnosis of Diabetes States.
    Vasu S; Kumano K; Darden CM; Rahman I; Lawrence MC; Naziruddin B
    Cells; 2019 Nov; 8(12):. PubMed ID: 31795194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases?
    Fichtlscherer S; Zeiher AM; Dimmeler S
    Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2383-90. PubMed ID: 22011751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNAs: early prognostic biomarkers for Type 2 diabetes mellitus?
    Bhatia P; Raina S; Chugh J; Sharma S
    Biomark Med; 2015; 9(10):1025-40. PubMed ID: 26441333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular microRNAs: as modulators and diagnostic biomarkers of diabetic heart disease.
    Rawal S; Manning P; Katare R
    Cardiovasc Diabetol; 2014 Feb; 13():44. PubMed ID: 24528626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial microparticles-incorporated microRNAs are altered in patients with diabetes mellitus.
    Jansen F; Wang H; Przybilla D; Franklin BS; Dolf A; Pfeifer P; Schmitz T; Flender A; Endl E; Nickenig G; Werner N
    Cardiovasc Diabetol; 2016 Mar; 15():49. PubMed ID: 27005938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial Microparticles Act as Novel Diagnostic and Therapeutic Biomarkers of Diabetes and Its Complications: A Literature Review.
    Deng F; Wang S; Zhang L
    Biomed Res Int; 2016; 2016():9802026. PubMed ID: 27803933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-derived miR-103b as a novel biomarker for the early diagnosis of type 2 diabetes.
    Luo M; Li R; Deng X; Ren M; Chen N; Zeng M; Yan K; Xia J; Liu F; Ma W; Yang Y; Wan Q; Wu J
    Acta Diabetol; 2015 Oct; 52(5):943-9. PubMed ID: 25820527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNA-320a and microRNA-486 predict thiazolidinedione response: Moving towards precision health for diabetes prevention.
    Flowers E; Aouizerat BE; Abbasi F; Lamendola C; Grove KM; Fukuoka Y; Reaven GM
    Metabolism; 2015 Sep; 64(9):1051-9. PubMed ID: 26031505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulated miR-103 and miR-143 expression in peripheral blood mononuclear cells from induced prediabetes and type 2 diabetes rats.
    Vatandoost N; Amini M; Iraj B; Momenzadeh S; Salehi R
    Gene; 2015 Nov; 572(1):95-100. PubMed ID: 26164754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered profile of serum microRNAs in pancreatic cancer-associated new-onset diabetes mellitus.
    Dai X; Pang W; Zhou Y; Yao W; Xia L; Wang C; Chen X; Zen K; Zhang CY; Yuan Y
    J Diabetes; 2016 May; 8(3):422-33. PubMed ID: 25991015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating microRNAs are associated with variability in fasting blood glucose over 12-months and target pathways related to type 2 diabetes: A pilot study.
    Flowers E; Allen IE; Kanaya AM; Aouizerat BE
    Diab Vasc Dis Res; 2021; 18(6):14791641211055837. PubMed ID: 34846185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus].
    Ozawa H; Murai Y; Ozawa T
    Yakushigaku Zasshi; 2003; 38(1):11-27. PubMed ID: 14570054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are extracellular microRNAs involved in type 2 diabetes and related pathologies?
    Rome S
    Clin Biochem; 2013 Jul; 46(10-11):937-45. PubMed ID: 23499584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNAs and diabetes: potential applications in medical practice.
    Raffort J; Hinault C; Dumortier O; Van Obberghen E
    Diabetologia; 2015 Sep; 58(9):1978-92. PubMed ID: 26155747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute strength training promotes responses in whole blood circulating levels of miR-146a among older adults with type 2 diabetes mellitus.
    Morais Junior GS; Souza VC; Machado-Silva W; Henriques AD; Melo Alves A; Barbosa Morais D; Nóbrega OT; Brito CJ; Dos Santos Silva RJ
    Clin Interv Aging; 2017; 12():1443-1450. PubMed ID: 28979106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs and adipocytokines: Promising biomarkers for pharmacological targets in diabetes mellitus and its complications.
    Ashoori MR; Rahmati-Yamchi M; Ostadrahimi A; Fekri Aval S; Zarghami N
    Biomed Pharmacother; 2017 Sep; 93():1326-1336. PubMed ID: 28747014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.